Indasi Lifescience Private Limited — Artesunate Exporter Profile
Indian Pharmaceutical Exporter · #8 for Artesunate · $2.3M export value · DGFT Verified
Indasi Lifescience Private Limited is the #8 Indian exporter of Artesunate with $2.3M in export value and 63 verified shipments. Indasi Lifescience Private Limited holds a 1.3% market share in Artesunate exports across 4 countries. The company exports 2 pharmaceutical products worth $2.4M across 2 therapeutic categories.
Indasi Lifescience Private Limited — Artesunate Export Profile: Buyers & Destinations
Where Does Indasi Lifescience Private Limited Export Artesunate?
| Country | Value | Shipments | Share |
|---|---|---|---|
| KENYA | $1.4M | 38 | 71.7% |
| GHANA | $400.1K | 21 | 20.1% |
| UGANDA | $144.0K | 4 | 7.2% |
| EQUATORIAL GUINEA | $19.0K | 1 | 1.0% |
Indasi Lifescience Private Limited exports Artesunate to 4 countries. The largest destination is KENYA accounting for 71.7% of Indasi Lifescience Private Limited's Artesunate shipments, followed by GHANA (20.1%) and UGANDA (7.2%). These destinations reflect Indasi Lifescience Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Artesunate from Indasi Lifescience Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ROYAL PHARMA 2011 LTD | KENYA | $917.4K | 26 |
| ROYAL PHARMA 2011 LIMITED | KENYA | $320.5K | 8 |
| NOVOMED HEALTHCARE LTD | UGANDA | $230.3K | 5 |
| HABMAY PHARMACY LTD | GHANA | $191.4K | 9 |
| HABMAY PHARMACY LTD. | GHANA | $142.8K | 9 |
| HABMAY PHARMACY LIMITED | GHANA | $65.9K | 3 |
| ROYAL PHARMA 2011 LTD. | KENYA | $50.0K | 1 |
| GEFARMA . SL | EQUATORIAL GUINEA | $19.0K | 1 |
Indasi Lifescience Private Limited supplies Artesunate to 8 buyers globally. The largest buyer is ROYAL PHARMA 2011 LTD (KENYA), followed by ROYAL PHARMA 2011 LIMITED (KENYA) and NOVOMED HEALTHCARE LTD (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Artesunate Export Value and How Much Does Indasi Lifescience Private Limited Contribute?
India exported $71.2M worth of Artesunate through 6,110 shipments from 441 suppliers to 102 countries, serving 1,052 buyers globally. Indasi Lifescience Private Limited contributes $2.3M to this total, accounting for 1.3% of India's Artesunate exports. Indasi Lifescience Private Limited ships Artesunate to 4 countries through 8 buyers.
What Is the Average Shipment Value for Indasi Lifescience Private Limited's Artesunate Exports?
Indasi Lifescience Private Limited's average Artesunate shipment value is $36.0K per consignment, based on 63 shipments totaling $2.3M. The largest destination is KENYA (71.7% of Indasi Lifescience Private Limited's Artesunate exports).
How Does Indasi Lifescience Private Limited Compare to Other Indian Artesunate Exporters?
Indasi Lifescience Private Limited ranks #8 among 441 Indian Artesunate exporters with a 1.3% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($21.1M), AFROWAY PHARMA ($15.9M), LINCOLN PHARMACEUTICALS LTD ($7.6M). Indasi Lifescience Private Limited processed 63 shipments to 4 destination countries.
What Artesunate Formulations Does Indasi Lifescience Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ARTESUNATE FOR INJECTION 60 MG(WITH DILU | $300.0K | 6 |
| ARTESUNATE FOR INJECTION 60 MG (WITH DILUENT) (DETAILS AS PER INVOICE AND PACKING LIST) | $256.3K | 9 |
| ARTESUNATE FOR INJECTION 60 MG (WITH DILUENT) (DETAILS AS PER INVOICE AND PACKING LIST)NOS | $211.3K | 9 |
| ARTESUNATE FOR INJECTION 60 MG WITH DI | $200.0K | 4 |
| ARCELIA (ARTESUNATE INJ 60MG IN VIAL WITH DILUENT) | $130.3K | 3 |
| ARTESUNATE FOR INJECTION 60 MG WITH DILUENT DETAILS AS PER DOCUMENT AND PACKING LIST | $100.0K | 2 |
| HABINATE 120 ( ARTESUNATE INJECTION 120MG ) | $68.3K | 3 |
| HABINATE 120 MG ARTESUNATE FOR INJECTION | $50.4K | 2 |
| ARTESUNATE FOR INJECTION 60 MG (WITH DI | $50.0K | 1 |
| ARTESUNATE FOR INJECTION 120MG (WITH DILUENT) (DETAILS AS PER INVOICE AND PACKING LIST) | $50.0K | 1 |
Indasi Lifescience Private Limited exports 28 distinct Artesunate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ARTESUNATE FOR INJECTION 60 MG(WITH DILU with 6 shipments worth $300.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Indasi Lifescience Private Limited Compare to Nearest Artesunate Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | SCOTT EDIL PHARMACIA LIMITED | $3.2M | 74 | 9 | $43.1K |
| 7 | BIOMATRIX HEALTHCARE PRIVATE LIMITED | $2.8M | 98 | 5 | $28.2K |
| 8 | INDASI LIFESCIENCE PRIVATE LIMITED ★ | $2.3M | 63 | 4 | $36.0K |
| 9 | CAPLIN POINT LABORATORIES LIMITED | $2.0M | 49 | 3 | $40.8K |
| 10 | INTERMED LABORATORIES PRIVATE LIMITED | $1.6M | 58 | 1 | $28.0K |
Indasi Lifescience Private Limited ranks #8 among 441 Indian Artesunate exporters. Average shipment value of $36.0K compared to the market average of $161.4K. The closest competitors by value are SCOTT EDIL PHARMACIA LIMITED and BIOMATRIX HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Artesunate Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 902 | 14.8% |
| JNPT | 533 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 515 | 8.4% |
| AHEMDABAD ICD (INSBI6) | 423 | 6.9% |
| AHEMDABAD ICD | 419 | 6.9% |
| SAHAR AIR | 396 | 6.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 354 | 5.8% |
| NHAVA SHEVA SEA | 172 | 2.8% |
About Indasi Lifescience Private Limited
Indasi Lifescience Private Limited exports 2 products worth $2.4M. Beyond Artesunate, top products include Fosfomycin. View the complete Indasi Lifescience Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Artesunate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Artesunate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Indasi Lifescience Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 64 individual customs records matching Indasi Lifescience Private Limited exporting Artesunate, covering 28 formulations to 4 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 102+ countries, 1,052+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Artesunate Export Data from Indasi Lifescience Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Indasi Lifescience Private Limited's Artesunate exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Indasi Lifescience Private Limited
Full Company Profile →
2 products · $2.4M total trade · 2 categories
Artesunate Stats
Company Overview
Top Products by Indasi Lifescience Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Indasi Lifescience Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Artesunate. For current shipment-level data, contact TransData Nexus.